People: Alere Inc (ALR)

Summary

Name	Age	Since	Current Position
Ron Zwanziger	58	2001	Chairman of the Board, President, Chief Executive Officer
David Teitel	48	2006	Chief Financial Officer, Vice President, Treasurer
Michael Cotton	50	2012	President and Chief Executive Officer of Alere Health, LLC
Hilde Eylenbosch	48	2012	President, Europe and Middle East
James Post	49	2011	President of Alere North America, Inc.
David Toohey	55	2011	President - International Business Operations
David Walton	58	2012	President, Asia Pacific
Namal Nawana	42	2012	Chief Operating Officer
Paul Hempel	63	2010	Senior Vice President - Ethics/Compliance, Special Counsel, Assistant Secretary
Jerry McAleer	56	2010	Senior Vice President - Research and Development, Director
John Bridgen	65	2010	Senior Vice President - Business Development
David Scott	55	2001	Chief Scientific Officer, Director
Jon Russell	47	2011	Vice President - Finance; President of Alere Home Monitoring, Inc.
Ellen Chiniara	53	2010	Vice President, General Counsel, Secretary
Robert Di Tullio	58	2010	Vice President - Global Regulatory and Clinical Affairs
Robert Hargadon	55	2010	Vice President - Global Culture and Performance
Emmanuel Hart	62	2009	Vice President, LAmARCIS
Josef Leiter		2011	Advisor to Chief Executive Officer
Gordon Norman	63	2010	Chief Innovation Officer
Eli Adashi	67	2009	Independent Director
Carol Goldberg	81	2001	Independent Director
Robert Khederian	59	2001	Independent Director
John Levy	57	2001	Independent Director
John Quelch	60	2003	Independent Director
James Roosevelt	66	2009	Independent Director
Peter Townsend	77	2001	Independent Director

» Insider Trading

Biographies

Name	Description
Ron Zwanziger	Mr. Ron Zwanziger is Chairman of the Board, President, Chief Executive Officer of Alere, Inc., since May 11, 2001. Mr. Zwanziger served as Chairman, Chief Executive Officer and President of company's predecessor company, Inverness Medical Technology, from its inception in 1992 through November 2001, when that company was acquired by Johnson & Johnson. From 1981 to 1991, he was Chairman and Chief Executive Officer of MediSense, a medical device company. Mr. Zwanziger served as a director of AMAG Pharmaceuticals, Inc. from November 2006 to December 2011.
David Teitel	Mr. David Teitel is Chief Financial Officer, Vice President, Treasurer of Alere, Inc. Mr. Teitel has over 25 years of public and private company finance experience, including nine years of audit experience at Arthur Andersen and senior financial positions with Thermo Electron Corp., which is now Thermo Fisher Scientific Inc. and Deknatel Snowden Pencer, Inc. Mr. Teitel joined the Company in December 2003 as Director of Finance Operations and assumed the title Vice President, Finance in December 2004.
Michael Cotton	Mr. Michael Lester Cotton serves as President and Chief Executive Officer of Alere Health, LLC, subsidiary of Alere, Inc. Previously, he joined Alere Health in September 2010 as President of Alere Health’s Health Improvement division. Mr. Cotton came to Alere from WellCare Health Plans, Inc., where he served as President of National Health Plans from March 2010 until September 2010; President, South Region from February 2009 to February 2010; President, Georgia from February 2008 to February 2009; Chief Operating Officer for Georgia from April 2006 to February 2008; and Chief Operating Officer for Ohio from December 2005 to April 2006. Prior to joining WellCare, Mr. Cotton served as a worldwide partner for Mercer LLC from October 2001 to December 2005. Prior to October 2001, Mr. Cotton held the positions of President and Chief Executive Officer of Mid-Valley CareNet, a physician hospital organization (PHO) with more than 600 physician members.
Hilde Eylenbosch	Dr. Hilde Eylenbosch, M.D., is President, Europe and Middle East of Alere, Inc. Previously, she served as Chief Commercial Officer since November 2010, after having served as Senior Vice President, Marketing from July 2010 to November 2010 and as Vice President, Marketing from April 2009 to July 2010. Prior to April 2009, she served as Chief Executive Officer of SPD Swiss Precision Diagnostics GmbH, 50/50 joint venture with Procter & Gamble, since its inception on May 18, 2007. Dr. Eylenbosch has also served as President, Consumer Diagnostics since June 2006. Prior to assuming that title she served as Vice President, Consumer Diagnostics from July 2005 to June 2006, Vice President, Consumer Marketing from October 2004 to July 2005 and Vice President of International Women’s Health from November 2001 to October 2004. Dr. Eylenbosch served in the same capacity for company's predecessor company, Inverness Medical Technology, from August 2001 until that company was acquired by Johnson & Johnson in November 2001. Prior to that, she held various positions at Inverness Medical Technology, including Director of U.S. Women’s Health from September 1998 through October 2000. When she joined Inverness Medical Technology in January 1995, Dr. Eylenbosch was responsible for marketing that company’s women’s health products in Europe. Before joining Inverness Medical Technology, Dr. Eylenbosch was employed by Synthelabo, a French pharmaceutical company, where she held various marketing positions.
James Post	Mr. James Post serves as President of Alere North America, Inc., subsidiary of Alere, Inc. Mr. Post was Vice President of Sales and Marketing for Critical Care division from March 2008 until October 2010. From January 2003 to February 2008, Mr. Post served as the Northeast Regional Sales Director for Biosite Incorporated, which the company acquired in June 2007. Mr. Post has been with Alere for 10 years. Previously, Mr. Post was the Vice President at US Surgical Corporation the commercial team in the U.S. Mr. Post’s career has focused on solutions to help improve clinical and economic outcomes for hospitals and physician offices through innovative solutions development, customer education, and a commitment to a customer-centric culture.
David Toohey	Mr. David Toohey is President - International Business Operations of Alere, Inc. He is the President and Managing Director of Alere International Ltd. Prior to his appointment, Mr. Toohey served in a variety of roles with the company, including as President, Europe/Middle East from January 2008 to January 2011; President, Professional Diagnostics from December 2005 to January 2008; Vice President, Professional Diagnostics from October 2002 to January 2008; Vice President, European Operations from February 2002 to October 2002; and as Vice President, New Products from November 2001 to October 2002. Mr. Toohey also served as Managing Director of Unipath Limited subsidiary from December 2001 through October 2002. Mr. Toohey was employed by predecessor company, Inverness Medical Technology, as its Vice President, New Products from May 2001 through November 2001, when that company was acquired by Johnson & Johnson. Prior to joining Inverness Medical Technology, Mr. Toohey served as Vice President of Operations at Boston Scientific Corporation’s Galway, Ireland facility where he oversaw its growth, from a start-up to Boston Scientific Corporation’s international facility, between 1995 and 2001. Prior to that time he held various executive positions at Bausch & Lomb, Inc., Digital Equipment Corp. and Mars, Inc.
David Walton	Mr. David Walton serves as President, Asia Pacific of Alere, Inc. Mr. Walton joined the Company in December 2001 when the company acquired the Unipath business from Unliever plc, where he was International Director for the Consumer and Professional Diagnostic business units. From 2007 until February 2012, he was responsible for building and integrating company's businesses in Asia Pacific as Vice President, Asia Pacific. Additionally, from November 2010 until February 2011, he was President of both company's European and Middle East business and Asia Pacific business. Prior to joining the company, Mr. Walton held various senior global sales and marketing roles in the diagnostics division of Eli Lilly and Company, Bio-Rad Laboratories, Inc. and Corning Medical, U.K.
Namal Nawana	Mr. Namal Nawana has been appointed as the Chief Operating Officer of Alere Inc. effective December 30, 2012. He comes to Alere from Johnson & Johnson, where he has spent 15 years in various leadership roles, spanning the fields of engineering, marketing, sales and general management, including in Canada, Europe, the United States and the Asia Pacific region. Most recently, Mr. Nawana served as the Worldwide President of DePuy Synthes Spine, a Johnson & Johnson company, responsible for, among other things, managing all operations globally. Prior to that, he was Area Vice President for Johnson & Johnson Medical’s operations in Australia and New Zealand, Chairman of the DePuy Asia Pacific Franchise Council, General Manager for DePuy Australia and General Manager for DePuy Canada.
Paul Hempel	Mr. Paul T. Hempel is Senior Vice President - Ethics/Compliance, Special Counsel, Assistant Secretary of Alere, Inc. He served as General Counsel and Secretary from company's inception on May 11, 2001 until April 2006, when Mr. Hempel became Senior Vice President in charge of Leadership Development and Special Counsel, while retaining his role as Ethics Officer and his role as Secretary, which he retained until May 2010. Mr. Hempel also retained oversight of legal affairs until May 2007. In November 2010, Mr. Hempel became Senior Vice President, Ethics/Compliance and Special Counsel. Mr. Hempel served as General Counsel and Assistant Secretary of company's predecessor company, Inverness Medical Technology, from October 2000 through November 2001, when that company was acquired by Johnson & Johnson. Prior to joining Inverness Medical Technology, he was a founding stockholder and Managing Partner of Erickson Schaffer Peterson Hempel & Israel PC from 1996 to 2000. Prior to 1996, Mr. Hempel was a partner and managed the business practice at Bowditch & Dewey LLP.
Jerry McAleer	Dr. Jerry McAleer, Ph.D., is Senior Vice President - Research and Development, Director of Alere, Inc. He joined the Board on March 10, 2003. Dr. McAleer became Senior Vice President, Research and Development in July 2010. Prior to that, he served as Vice President, Research and Development since company's inception in May 2001 and as Vice President, Cardiology since early 2006. Dr. McAleer served as Vice President of Research and Development of company's predecessor company, Inverness Medical Technology, from 1999 through November 2001, when that company was acquired by Johnson & Johnson. From 1995 to 1999, Dr. McAleer served as Director of Development of Inverness Medical Limited, Inverness Medical Technology’s primary research and development unit, where he headed the development of Inverness Medical Technology’s electrochemical glucose strips. Prior to joining Inverness Medical Technology, Dr. McAleer held senior research and development positions at MediSense, a medical device company, and Ecossensors, Inc., an environmental research company.
John Bridgen	Dr. John Bridgen, Ph.D., is Senior Vice President - Business Development of Alere, Inc. He has served as Senior Vice President, Business Development since July 2010, after serving as Vice President, Business Development from June 2006 to July 2010. He served as Vice President, Strategy from September 2005 to June 2006. Dr. Bridgen joined the Company in September 2002, upon company's acquisition of Wampole Laboratories, LLC. Dr. Bridgen served as President of Wampole from August 1984 until September 2005. Prior to joining Wampole, Dr. Bridgen had global sales and marketing responsibility for the hematology and immunology business units of Ortho Diagnostic Systems Inc., a Johnson & Johnson company.
David Scott	Dr. David Scott, Ph.D., is Chief Scientific Officer and Director of Alere, Inc. Dr. Scott served as Chairman of Inverness Medical Limited, a subsidiary of company's predecessor company, Inverness Medical Technology, from July 1999 through November 2001, when that company was acquired by Johnson & Johnson, and as a managing director of Inverness Medical Limited from July 1995 to July 1999.
Jon Russell	Mr. Jon Russell is Vice President - Finance of Alere, Inc., and President of Alere Home Monitoring, Inc., subsidiary of the company. Since October 2011, Mr. Russell has also continued to serve as Vice President of Finance, a position he has held since 2006, and shares responsibility for external communications with the Chief Executive Officer. Previously, Mr. Russell was Chief Financial Officer of Wampole Laboratories, LLC from September 2005 to June 2006. He has more than 20 years of experience in finance and operations management, including senior operational finance positions in North America and Europe with Precision Castparts Corporation, Vertex Interactive, Inc. and Genicom Corporation. Mr. Russell began his career at Ernst & Young LLP.
Ellen Chiniara	Ms. Ellen Chiniara is Vice President, General Counsel, Secretary of Alere, Inc. She is responsible for managing legal matters for the Company. Ms. Chiniara joined the company in October 2006 as General Counsel, Professional Diagnostics and Assistant Secretary and became Vice President and General Counsel in May 2007 and Secretary in May 2010. From 2002 to 2006, Ms. Chiniara was Associate General Counsel, Neurology of Serono, Inc., a biopharmaceutical company. Previously, she served as General Counsel to a healthcare venture capital fund and a healthcare management services organization, where she also was Chief Operating Officer of its clinical trial site management division. From 1994 to 1997, Ms. Chiniara was Assistant General Counsel at Value Health, a specialty managed healthcare company where she focused on disease management and healthcare IT. Prior to 1994, Ms. Chiniara was a partner with Hale and Dorr (now WilmerHale).
Robert Di Tullio	Mr. Robert Di Tullio is Vice President - Global Regulatory and Clinical Affairs of Alere, Inc., since March 2010. He has over 38 years experience in the in vitro diagnostics industry, the last 27 of which have been in quality and regulatory management. Mr. Di Tullio served as Vice President, Regulatory Affairs and Quality at ProteoGenix, Inc., a diagnostic company, from July 2008 to March 2010. He held the position of Vice President, Regulatory and Clinical Affairs and Quality at Sequenom, Inc., a genetic analysis company, from June 2007 to July 2008. From June 1992 to June 2007, Mr. Di Tullio served as Vice President, Regulatory Affairs and Quality Systems at Diagnostic Products Corporation, or DPC, an immuno-diagnostics company, and Siemens Medical Solutions Diagnostics, following its acquisition of DPC. Mr. Di Tullio has been co-chair of the AdvaMed Dx task force since 2007.
Robert Hargadon	Mr. Robert Hargadon is Vice President - Global Culture and Performance of Alere, Inc. He has over 30 years of experience in human resources, leadership and organization development. Mr. Hargadon served as Vice President, Human Resources at drugstore.com, an online pharmacy, from November 2006 through October 2010. Prior to that, Mr. Hargadon was General Manager, Corporate Learning and Development at Microsoft from September 2005 to April 2006 and held various human resources leadership positions at Boston Scientific Corporation, a medical device manufacturer, from 1997 to 2005, including Vice President of International Human Resources and Vice President, Leadership Development from September 1997 to June 2005. Mr. Hargadon served as Vice President, Learning and Development at Fidelity Investments from 1993 to 1997. Mr. Hargadon also had 15 years of experience with the consulting firms Novations Group, Inc. and Harbridge House, which was acquired by PricewaterhouseCoopers LLP.
Emmanuel Hart	Mr. Emmanuel Hart serves as Vice President, LAmARCIS of Alere, Inc. He served as Chief Executive Officer and President of Orgenics Ltd. (Israel), one of company's subsidiaries, from July 1998 through 2007. Orgenics Ltd. includes manufacturing, research and development and marketing business units. In August 2007, Mr. Hart was appointed Vice President for International Business responsible for the Latin America, Africa, Russia, ex-Soviet Union countries and Israel territories (LAmARCIS) for all of company's products.
Josef Leiter	Dr. Josef M. E. Leiter, M.D., is no longer Advisor to Chief Executive Officer of Alere, Inc., effective September 30, 2013. Since 2003, Dr. Leiter has been the chief executive officer of Leiter & Cie, GmbH, a German private equity firm concentrating on the health care industry, which he founded. In this capacity, Dr. Leiter founded and developed several health care companies in Europe, and he has gained experience in the development of business models which invoke personal responsibility as a key driver for improving people’s health. Between 1996 and 2003, Dr. Leiter was a partner at the consulting firm of McKinsey & Company, where he advised health plans and pharmaceutical companies as well as smaller, innovation-driven companies and venture capital firms on a broad range of strategic, organizational and operational issues. Prior to his work at McKinsey, Dr. Leiter worked in the area of molecular virology at the Mount Sinai School of Medicine in New York, New York.
Gordon Norman	Dr. Gordon Norman, M.D., is Chief Innovation Officer of Alere, Inc., since February 2010. Since that time, Dr. Norman has also continued to serve as Executive Vice President and Chief Innovation Officer at company's subsidiary, Alere Health, LLC, where he held the title of Executive Vice President, Science & Innovation from May 2008 to February 2010. From June 2007 to May 2008, Dr. Norman served as Executive Vice President, Chief Science Officer of Alere Medical, Inc., which the company acquired in November 2007. From July 2005 to June 2007, Dr. Norman served Alere Medical as Executive Vice President and Chief Medical Officer. Prior to joining Alere Medical in July 2005, Dr. Norman served in a variety of executive medical management roles for PacifiCare Health Services beginning in July 1994.
Eli Adashi	Dr. Eli Y. Adashi, M.D., M.S., C.P.E., F.A.C.O.G., is Independent Director of Alere, Inc., since April 1, 2009. The immediate past Dean of Medicine and Biological Sciences and the Frank L. Day Professor of Biology at Brown University, Dr. Adashi—Harvard-educated in Health Care Management (M.S.; 2005; HSPH)—has been a Professor of Medical Science at Brown University since 2004. A Physician-Scientist-Executive with over 25 years of experience in healthcare and in the life sciences, Dr. Adashi is a member of the Institute of Medicine of the National Academy of Sciences and of its Board on Health Sciences Policy, the Council on Foreign Relations, the Association of American Physicians, and the American Association for the Advancement of Science. Dr. Adashi is a member of MEDCAC (Medicare Evidence Development & Coverage Advisory Committee) and an ad hoc member of the Reproductive Health Drugs Advisory Committee of the U.S. Food & Drug Administration. Dr. Adashi is the author or co-author of over 250 peer-reviewed publications, over 120 book chapters/reviews, and 13 books focusing on ovarian biology, reproductive health and domestic health policy. Dr. Adashi is a member of the Board’s Compensation Committee.
Carol Goldberg	Ms. Carol R. Goldberg is Independent Director of Alere, Inc., since May 30, 2001. Ms. Goldberg served as a director of the predecessor company, Inverness Medical Technology, from August 1992 through November 2001, when that company was acquired by Johnson & Johnson. Since December 1989, she has served as President of The AVCAR Group, Ltd., an investment and management consulting firm in Boston, Massachusetts. Ms. Goldberg is Chairperson of the Board’s Compensation Committee.
Robert Khederian	Mr. Robert P. Khederian is Independent Director of Alere, Inc., since July 31, 2001. Mr. Khederian is the Chairman of Belmont Capital, a venture capital firm he founded in 1996, and Provident Corporate Finance, an investment banking firm he founded in 1998. From 1984 through 1996, he was founder and Chairman of Medical Specialties Group, Inc., a nationwide distributor of medical products which was acquired by Bain Capital. Mr. Khederian served as the Chairman of the Board of Cambridge Heart, Inc. from August 2006 to August 2008. Mr. Khederian also served as the interim Chief Executive Officer of Cambridge Heart, Inc. from December 2006 to December 2007. Mr. Khederian is a member of the Board’s Audit Committee and Compensation Committee.
John Levy	Mr. John F. Levy is Independent Director of Alere, Inc., since May 30, 2001. Mr. Levy served as a director of Inverness Medical Technology from August 1996 through November 2001, when that company was acquired by Johnson & Johnson. Since 1993, he has been an independent consultant. Mr. Levy served as President and Chief Executive Officer of Waban, Inc., a warehouse merchandising company, from 1989 to 1993. Mr. Levy is Chairperson of the Board’s Audit Committee and is a member of the Board’s Nominating and Corporate Governance Committee.
John Quelch	Professor Dr. John A. Quelch, D.B.A., Ph.D., is Independent Director of Alere, Inc., since March 10, 2003. Since February 2011, Dr. Quelch has been Dean, Vice President and Distinguished Professor of International Management at the China Europe International Business School in Shanghai. From July 2001 through January 2011, he was Senior Associate Dean at the Harvard Business School. From July 1998 through June 2001, he was Dean of the London Business School. Dr. Quelch also serves as a director of WPP plc, the world’s marketing and media services company. Dr. Quelch served as a director of Pepsi Bottling Group from 2005 to 2010 and of Gentiva Health Services, Inc. from 2006 to 2009. He is Chairperson of the Board’s Nominating and Corporate Governance Committee.
James Roosevelt	Mr. James Roosevelt, Jr., is Independent Director of Alere, Inc., since February 6, 2009. Mr. Roosevelt has served as the President and Chief Executive Officer of Tufts Health Plan since 2005. From 1999 to 2005, Mr. Roosevelt was Senior Vice President and General Counsel of Tufts Health Plan. Mr. Roosevelt also serves as Co-Chair of the Rules and By-laws Committee of the Democratic National Committee, Co-Chair of the Board of Directors for the Tufts Health Care Institute, and member of the Board of Directors at American Health Insurance Plans and PointRight Inc., where he serves as a member of the Compensation Committee. Mr. Roosevelt is a member of the Board’s Nominating and Corporate Governance Committee.
Peter Townsend	Mr. Peter Townsend is Independent Director of Alere, Inc., since May 30, 2001. Mr. Townsend served as a director of the predecessor company, Inverness Medical Technology, from August 1996 through November 2001, when that company was acquired by Johnson & Johnson. From 1991 to 1995, when he retired, Mr. Townsend served as Chief Executive Officer and a director of Enviromed plc, a medical products company. Mr. Townsend is a member of the Board’s Audit Committee.

Basic Compensation

Name	Fiscal Year Total
Ron Zwanziger	900,713
David Teitel	476,609
Michael Cotton	--
Hilde Eylenbosch	1,071,480
James Post	--
David Toohey	688,842
David Walton	--
Namal Nawana	--
Paul Hempel	--
Jerry McAleer	523,740
John Bridgen	886,585
David Scott	546,028
Jon Russell	--
Ellen Chiniara	--
Robert Di Tullio	--
Robert Hargadon	--
Emmanuel Hart	--
Josef Leiter	956,471
Gordon Norman	--
Eli Adashi	--
Carol Goldberg	--
Robert Khederian	--
John Levy	--
John Quelch	--
James Roosevelt	--
Peter Townsend	--

As Of 30 Dec 2011

Options Compensation

Name	Options	Value
Ron Zwanziger	202,641	1,900,152
David Teitel	0	0
Michael Cotton	0	0
Hilde Eylenbosch	45,765	634,318
James Post	0	0
David Toohey	127,111	1,423,500
David Walton	0	0
Namal Nawana	0	0
Paul Hempel	0	0
Jerry McAleer	784,174	7,021,154
John Bridgen	106,664	610,862
David Scott	564,681	6,387,648
Jon Russell	0	0
Ellen Chiniara	0	0
Robert Di Tullio	0	0
Robert Hargadon	0	0
Emmanuel Hart	0	0
Josef Leiter	0	0
Gordon Norman	0	0
Eli Adashi	0	0
Carol Goldberg	0	0
Robert Khederian	0	0
John Levy	0	0
John Quelch	0	0
James Roosevelt	0	0
Peter Townsend	0	0

Insider Trading

Name	Shares Traded	Price
POST JAMES	1,075	$23.37
QUELCH JOHN A	20,220	$23.49
QUELCH JOHN A	25,000	$16.20
EYLENBOSCH HILDE	2,500	$16.20
EYLENBOSCH HILDE	2,391	$22.69
HART EMANUEL	635	$15.73
CHINIARA ELLEN V	509	$15.73
TEITEL DAVID M	381	$15.73
HEMPEL PAUL T	612	$15.73
POST JAMES	573	$15.73
POST JAMES	840	$18.77
TOOHEY DAVID	151	$15.55
TOOHEY DAVID	151	$18.28
BRIDGEN JOHN	11,721	$18.96
BRIDGEN JOHN	11,721	$11.75
LEVY JOHN F	4,000	$13.54
BRIDGEN JOHN	4,752	$20.00
BRIDGEN JOHN	4,752	$11.75
HEMPEL PAUL T	523	$16.52
HART EMANUEL	523	$16.52
TEITEL DAVID M	351	$16.52
CHINIARA ELLEN V	467	$16.52
ZWANZIGER RON	5,065	$15.55
HEMPEL PAUL T	200	$19.01
HEMPEL PAUL T	8,213	$19.00

» Full list on Insider Trading

People: Alere Inc (ALR)

Related Topics:

Summary

Biographies

Basic Compensation

Options Compensation

Related Topics: